Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
复制标题

DOI:
10.1038/s41467-023-38651-x
复制
发表时间:
2023-05-26
影响因子:
16.6
通讯作者:
Bell, John C.
Bell, John C.
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Azad, Taha;Rezaei, Reza;Singaravelu, Ragunath;Pelin, Adrian;Boulton, Stephen;Petryk, Julia;Onsu, Kemal Alper;Martin, Nikolas T.;Hoskin, Victoria;Ghahremani, Mina;Marotel, Marie;Marius, Ricardo;He, Xiaohong;Crupi, Mathieu J. F.;Hoang, Huy-Dung;Nik-Akhtar, Abolfazl;Ahmadi, Mahsa;Zamani, Nika Kooshki;Golshani, Ashkan;Alain, Tommy;Greer, Peter;Ardolino, Michele;Dickinson, Bryan C.;Tai, Lee-Hwa;Ilkow, Carolina S.;Bell, John C.

文献摘要

参考文献

被引文献

相似文献

痘苗病毒(VV)载体的大编码潜力是一个决定性的特征。然而,有限的调控开关可用于控制病毒复制以及转基因表达的时间和剂量,以促进安全和有效的有效载荷传递。在这里,我们调整药物控制的基因开关,以实现对病毒编码的转基因表达的控制,包括由FDA批准的雷帕霉素和多西环素控制的系统。使用核糖体图谱来表征病毒启动子的强度,我们合理地设计了不同药物诱导系统的操纵子元件与VV启动子的融合,以产生合成启动子,该合成启动子具有强大的诱导表达能力,且基线水平不可检测。我们还产生嵌合的合成启动子,促进VV编码的合成转基因网络的额外调节层。这些开关用于实现融合蛋白的诱导表达,有毒细胞因子的剂量控制传递,以及VV复制的化学调节。该工具箱使VV载体溶瘤病毒设计中转基因电路的精确调节成为可能。痘苗病毒(VV)载体的大编码潜力是一个决定性的特征。在这里,作者提出了痘苗病毒载体适应的化学发生开关,能够控制病毒复制和转基因表达的时间和剂量,实现复杂的可调转基因电路,并产生更安全、更有效的载体。
The large coding potential of vaccinia virus (VV) vectors is a defining feature. However, limited regulatory switches are available to control viral replication as well as timing and dosing of transgene expression in order to facilitate safe and efficacious payload delivery. Herein, we adapt drug-controlled gene switches to enable control of virally encoded transgene expression, including systems controlled by the FDA-approved rapamycin and doxycycline. Using ribosome profiling to characterize viral promoter strength, we rationally design fusions of the operator element of different drug-inducible systems with VV promoters to produce synthetic promoters yielding robust inducible expression with undetectable baseline levels. We also generate chimeric synthetic promoters facilitating additional regulatory layers for VV-encoded synthetic transgene networks. The switches are applied to enable inducible expression of fusogenic proteins, dose-controlled delivery of toxic cytokines, and chemical regulation of VV replication. This toolbox enables the precise modulation of transgene circuitry in VV-vectored oncolytic virus design. The large coding potential of vaccinia virus (VV) vectors is a defining feature. Here the authors present vaccinia virus vector-adapted chemogenetic switches enabling temporal and dose control of viral replication and transgene expression, implementation of complex tunable transgene circuitry, and generation of safer, more efficacious vectors.
DOI: 10.1016/0958-1669(94)90067-1
发表时间: 1994-01-01
影响因子: 7.7
作者:
Gossen, Manfred;Bonin, Angelika L.;Bujard, Hermann
通讯作者: Bujard, Hermann
DOI: 10.1111/nyas.12122
发表时间: 2013-01-01
期刊: PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: PRIX GALIEN USA 2012
影响因子: --
作者:
Lebwohl, David;Anak, Oezlem;Berg, William
通讯作者: Berg, William
溶瘤免疫疗法中的融合病毒。
DOI: 10.3390/cancers10070216
发表时间: 2018-06-26
期刊: Cancers
影响因子: 5.2
作者:
Krabbe T;Altomonte J
通讯作者: Altomonte J
DOI: 10.1038/nchembio.2299
发表时间: 2017-04
影响因子: 14.8
作者:
Pu J;Zinkus-Boltz J;Dickinson BC
通讯作者: Dickinson BC
DOI: 10.3390/biomedicines8110474
发表时间: 2020-11-05
期刊: Biomedicines
影响因子: 4.7
作者:
Everts A;Bergeman M;McFadden G;Kemp V
通讯作者: Kemp V